RESEARCH-USE BIOSIMILAR ANTIBODY
Abrezekimab
Antibody fragment · IgG1
Abrezekimab (UCB4144; VR 942) is a humanized, high-affinity, neutralizing anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents IL-13 binding to the IL-13 Rα1 subunit. Abrezekimab can be used for the research of asthma.
TARGETIL13
YAntibody fragment
CATALOGSC-BS-785
CATALOG NUMBERSC-BS-785
MOLECULAR WEIGHTApprox. 48.1 kDa
PRODUCT FORMATAntibody fragment
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Abrezekimab (UCB4144; VR 942) is a humanized, high-affinity, neutralizing anti-human-IL-13 antibody fragment that binds to IL-13. Abrezekimab prevents IL-13 binding to the IL-13 Rα1 subunit. Abrezekimab can be used for the research of asthma.
Abrezekimab is a recombinant research-use antibody directed against IL13.